Crump Institute for Molecular Imaging, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA.
Department of Molecular & Medical Pharmacology, University of California Los Angeles (UCLA), Los Angeles, CA 90095, USA.
Molecules. 2024 Sep 26;29(19):4572. doi: 10.3390/molecules29194572.
The radiometal gallium-68 (Ga-68) has garnered significant interest due to its convenient production via compact and widely available generators and the high performance of Ga-labeled compounds for positron-emission tomography (PET) imaging for cancer diagnosis and management of patients undergoing targeted radionuclide therapy. Given the short half life of Ga-68 (68 min), microfluidic-based radiosynthesis is a promising avenue to establish very rapid, efficient, and routine radiolabeling with Ga-68; however, the typical elution volume of Ga-68 from a generator (4-10 mL) is incompatible with the microliter reaction volumes of microfluidic devices. To bridge this gap, we developed a microscale cartridge-based approach to concentrate Ga-68. By optimizing cartridge design, resin type, resin mass, and eluent composition, Ga-68 was reliably concentrated from ~6 mL to ~80 µL with high recovery efficiency (>97%, n = 14). Furthermore, this method is suitable for both single- and dual-generator setups. To demonstrate suitability of the concentrated radiometal for radiolabeling, we performed microdroplet synthesis of [Ga]Ga-PSMA-11, achieving high radiochemical yield (83 ± 11%, n = 3), excellent radiochemical purity (>99%), and high apparent specific activity (255-320 MBq/μg). The entire process, including Ga-68 concentration, radiosynthesis, purification, and formulation, was completed in 12 min. Starting with activity of 0.81-0.84 GBq, 0.51-0.64 GBq of product was produced, sufficient for multiple patient doses. This work paves the way to clinical-scale production of other Ga-labeled compounds using droplet microreactor methods, or high-throughput labeling optimization or compound screening of Ga-labeled probes using droplet reaction arrays.
放射性金属镓-68(Ga-68)因其通过紧凑且广泛可用的发生器方便地生产,以及用于正电子发射断层扫描(PET)成像的 Ga 标记化合物在癌症诊断和接受靶向放射性核素治疗的患者管理中的高性能而引起了极大的兴趣。鉴于 Ga-68 的半衰期短(68 分钟),基于微流控的放射合成是建立非常快速、高效和常规 Ga-68 标记的有前途的途径;然而,从发生器洗脱 Ga-68 的典型洗脱体积(4-10 毫升)与微流控设备的微升反应体积不兼容。为了弥补这一差距,我们开发了一种基于微尺度盒的浓缩 Ga-68 的方法。通过优化盒设计、树脂类型、树脂质量和洗脱剂组成,可靠地将 Ga-68 从约 6 毫升浓缩至约 80 µL,回收率>97%(n = 14)。此外,该方法适用于单发生器和双发生器设置。为了证明浓缩放射性金属对放射性标记的适用性,我们进行了[Ga]Ga-PSMA-11 的微滴合成,实现了高放射化学产率(83 ± 11%,n = 3)、极好的放射化学纯度(>99%)和高表观比活度(255-320 MBq/μg)。整个过程包括 Ga-68 浓缩、放射合成、纯化和配方,在 12 分钟内完成。从 0.81-0.84GBq 的活度开始,可生产 0.51-0.64GBq 的产物,足以满足多个患者的剂量。这项工作为使用液滴微反应器方法进行其他 Ga 标记化合物的临床规模生产,或使用液滴反应阵列进行 Ga 标记探针的高通量标记优化或化合物筛选铺平了道路。